Created a customized, comprehensive genomic profiling platform
An advanced genomic tool for precise cancer diagnoses and individually-tailored treatment
Based on a deep knowledge of the Next Generation Sequencing (NGS) platforms used by leading institutions worldwide, Dr. Cabanillas led the development and validation of ONCOgenics™, a unique test for cancer patients. This customized comprehensive genomic profiling tool summarizes molecular information in a ‘physician-friendly’ report, making it useful for adapting treatment for individuals and identifying hereditary predispositions.
At the cutting edge of Precision Medicine technology when we developed it, this novel molecular diagnostic platform for somatic and germline precision oncology positively influenced the landscape of personalized treatment. It is still one of the most advanced genomic tools for cancer characterization.
